SCHEMBL28297923

SCHEMBL28297923

O=C(O)C1CC(c2ccc(OC(F)(F)F)cc2)=NN(c2cccc(F)c2)C1=O

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KDM4E B2RXH2 1/20 0.41
SLC5A1 P13866 4/20 0.40
NOTUM Q6P988 1/20 0.39
FFAR4 Q5NUL3 2/20 0.39
LIPE Q05469 1/20 0.38
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
ABL1 P00519 1/20 0.37
CACNA1H O95180 1/20 0.37
MAOB P27338 2/20 0.37
NR3C2 P08235 2/20 0.36
MAOA P21397 1/20 0.36
ATM Q13315 1/20 0.36
SCN10A Q9Y5Y9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30187456 0.89 MEN1 (0.41) MEN1KMT2ASMN1; SMN2KDM4ESLC5A1
SCHEMBL19643410 0.89 MEN1 (0.41) MEN1KMT2ASMN1; SMN2KDM4ESLC5A1
SCHEMBL28873447 0.88 KDM4E (0.51) MEN1KMT2AKDM4EPDE4APDE4B
SCHEMBL28299533 0.86 KDM4E (0.41) MEN1KMT2AKDM4EPDE4APDE4B
SCHEMBL19660003 0.85 PDE4A (0.51) MEN1KMT2ASMN1; SMN2KDM4ESLC5A1
SCHEMBL28297925 0.82 CACNA1H (0.39) MEN1KMT2AKDM4EPDE4APDE4B
SCHEMBL28299380 0.82 MEN1 (0.49) MEN1KMT2ASMN1; SMN2KDM4EPDE4A
SCHEMBL19642610 0.79 KDM4E (0.48) MEN1KMT2AKDM4EPDE4APDE4B
SCHEMBL30187464 0.79 KDM4E (0.48) MEN1KMT2AKDM4EPDE4APDE4B
SCHEMBL28297926 0.78 PDE4A (0.46) MEN1KMT2ASMN1; SMN2SLC5A1PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109863140-A 3- oxo -2,6- diphenyl -2,3- dihydrogen dazin -4- formamide 拜耳医药股份有限公司 2019-06-07 CN disclosed